OUTLOOK THERAPEUTICS, INC. State and Local Income Tax Expense (Benefit), Continuing Operations
OUTLOOK THERAPEUTICS, INC. (OTLK) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $2.80 thousand for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2025-12-19
- OUTLOOK THERAPEUTICS, INC. state and local income tax expense (benefit), continuing operations for fiscal 2025 was $2.80K, a 0.00% change from fiscal 2024.
- OUTLOOK THERAPEUTICS, INC. state and local income tax expense (benefit), continuing operations for fiscal 2024 was $2.80K.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2025-09-30 | $2.80K 10-K · filed 2025-12-19 |
| 2024-09-30 | $2.80K 10-K · filed 2025-12-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |